FFAR4 and Peritoneal Fibrosis: Treatment with omega-3 PUFAs restored FFAR4 expression, improving peritoneal fibrosis by inhibiting hyperglycolysis and the MMT via the activation of the FFAR4/CaMKKβ/AMPK pathway and the suppression of mTOR phosphorylation [195].